SAMSARA BIOCAPITAL, LLC

HTTP://WWW.SAMSARACAP.COM/ PALO ALTO, CA Venture Capital Fund Investment Advisor How do I update this listing?

Samsara Biocapital is based out of Palo Alto. Samsara Biocapital is a large advisory firm with 1 clients and discretionary assets under management (AUM) of $404,878,345 (Form ADV from 2019-03-30). Their last reported 13F filing for Q1 2019 included $127,246,000 in managed 13F securities and a top 10 holdings concentration of 92.09%. Samsara Biocapital's largest holding is Intercept Pharmaceuticals Inc with shares held of 210,937. Whalewisdom has at least 2 13F filings The firm last filed a Form D notice of exempt offering of securities on 2018-04-20. The filing was for a pooled investment fund: venture capital fund The notice included securities offered of Equity,Pooled Investment Fund Interests

Download 13F Summary to Excel Create Email Alert

03/31/2019

13F Sector Allocation Over Time

03/31/2019

13F Activity

  • Market Value $127.246 Million
  • Prior Market Value $104.187 Million
  • New Purchases2 stocks
  • Additional Purchases2 stocks
  • Sold out of1 stock
  • Reduced holdings in4 stocks
  • Top 10 Holdings % 92.09 %
  • Turnover % [1]:16.67%
  • Turnover Alt % [2]: 14.99 %
  • Time Held Top20:0.89 quarters
  • Time Held Top10:0.80 quarters
  • Time Held All:0.89 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

Portfolio Performance

Top 20 equal-weighted holdings. Performance numbers calculated through 2019-05-15

Performance for Q1 2019: -4.08%
Performance Last 4 Quarters: 0.0%
Performance Metrics
Stats are not available for the latest quarter

Refresh Advanced Export Download CSV Download Excel (.xlsx) Download TSV
Filter by:

Security Types:

Refresh
*Shares are split adjusted
Click here to report any possible errors with this listing.
13F Filings Available:
  • 2019-03-31 - 13F-HR (Subscription required)
  • 2018-12-31 - 13F-HR (Subscription required)

View Last Form Adv Compilation Report on Record

SAMSARA BIOCAPITAL, LLC
Classified as Hedge Fund

  

Business Phone: 650-285-4270
Fax: (425) 328-3517
Professional Investment Advisor Data
SEC Registration as : Large Advisory Firm
Form of Organization: Limited Liability Company
Organized in: DE
Number of employees: 8
Other Business Activities:
Advisor Fees/Compensation: Percentage of assets under management,Performance-based fees
Amount of client funds and securities: 404,878,000
Total Number of Clients: 1
Amount of client funds and securities by related persons: 404,878,000
Total Number of clients from related persons: 1
Disclosures:
Data above was derived from SEC filings.

Active Schedule 13D and 13G events

Sign in to see

Form 4 - Recent Insider Transactions

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2018-04-20 D/A POOLED INVESTMENT FUND: VENTURE CAPITAL FUND Equity,Pooled Investment Fund Interests 310,090,000 310,090,000 0
2018-03-22 D/A POOLED INVESTMENT FUND: VENTURE CAPITAL FUND Equity,Pooled Investment Fund Interests 300,000,000 260,590,000 39,410,000
2017-03-21 D POOLED INVESTMENT FUND: VENTURE CAPITAL FUND Pooled Investment Fund Interests 300,000,000 0 300,000,000
Other Issuers in Filings
Name Address
SAMSARA BIOCAPITAL, L.P. 565 EVERETT AVENUE
PALO ALTO, CA 94301
SAMSARA BIOCAPITAL, L.P. 628 MIDDLEFIELD ROAD
PALO ALTO, CA 94301
Related Parties included in filings
Name Address Relationship
MICHAEL DYBBS subscription required
    DIRECTOR
N/A N/A SAMSARA BIOCAPITAL GP, LLC subscription required
    DIRECTOR
SRINIVAS AKKARAJU subscription required
    DIRECTOR

SAMSARA BIOCAPITAL, LLC

ownership team - last updated 2019-03-30
Name Title Start Date Direct/Indirect % Ownership
AKKARAJU, SRINIVAS MANAGER OF SAMSARA BIOCAPITAL, LLC 09/01/2016 Direct 75% or more
Fund Name Position direct/indirect start date end date
SAMSARA BIOCAPITAL, LLC MANAGER OF SAMSARA BIOCAPITAL, LLC direct 2016-09-01
VAN DOREN, RICHARD, D. CFO AND CCO 02/01/2017 Direct less than 5%
Fund Name Position direct/indirect start date end date
MCGUIRE, RICHARD T. CHIEF FINANCIAL OFFICER/CHIEF COMPLIANCE OFFICER direct 2010-05-01
MARCATO CAPITAL MANAGEMENT LP CHIEF FINANCIAL OFFICER direct 2010-05-01
PACIFIC GROVE CAPITAL LP CHIEF OPERATING OFFICER; CCO direct 2014-04-01
Dybbs, Michael, P. PARTNER 02/01/2017 Direct less than 5%
Fund Name Position direct/indirect start date end date
SAMSARA BIOCAPITAL, LLC PARTNER direct 2017-02-01

Private Funds

Name Country Fund Identification Number Fund Type Gross Asset Value Minimum Investment Other
SAMSARA BIOCAPITAL, L.P. United States 805-8756530482 Venture Capital Fund 404,878,345 160,000

SAMSARA BIOCAPITAL, LLC

ownership team - last updated 2018-06-28
Name Title Start Date Direct/Indirect % Ownership
AKKARAJU, SRINIVAS MANAGER OF SAMSARA BIOCAPITAL, LLC 09/01/2016 Direct 75% or more
Fund Name Position direct/indirect start date end date
SAMSARA BIOCAPITAL, LLC MANAGER OF SAMSARA BIOCAPITAL, LLC direct 2016-09-01
VAN DOREN, RICHARD, D. CFO AND CCO 02/01/2017 Direct less than 5%
Fund Name Position direct/indirect start date end date
MCGUIRE, RICHARD T. CHIEF FINANCIAL OFFICER/CHIEF COMPLIANCE OFFICER direct 2010-05-01
MARCATO CAPITAL MANAGEMENT LP CHIEF FINANCIAL OFFICER direct 2010-05-01
PACIFIC GROVE CAPITAL LP CHIEF OPERATING OFFICER; CCO direct 2014-04-01
Dybbs, Michael, P. PARTNER 02/01/2017 Direct less than 5%
Fund Name Position direct/indirect start date end date
SAMSARA BIOCAPITAL, LLC PARTNER direct 2017-02-01

Private Funds

Name Country Fund Identification Number Fund Type Gross Asset Value Minimum Investment Other
SAMSARA BIOCAPITAL, L.P. United States 805-8756530482 Venture Capital Fund 309,232,892 160,000

Elevate your investments